IL137672A0 - Derivatives of branched-chain lipophilic molecules and uses thereof - Google Patents

Derivatives of branched-chain lipophilic molecules and uses thereof

Info

Publication number
IL137672A0
IL137672A0 IL13767200A IL13767200A IL137672A0 IL 137672 A0 IL137672 A0 IL 137672A0 IL 13767200 A IL13767200 A IL 13767200A IL 13767200 A IL13767200 A IL 13767200A IL 137672 A0 IL137672 A0 IL 137672A0
Authority
IL
Israel
Prior art keywords
branched
derivatives
lipophilic molecules
chain lipophilic
chain
Prior art date
Application number
IL13767200A
Other languages
English (en)
Original Assignee
Dpharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dpharm Ltd filed Critical Dpharm Ltd
Priority to IL13767200A priority Critical patent/IL137672A0/xx
Priority to IL15424601A priority patent/IL154246A0/xx
Priority to HU0301711A priority patent/HUP0301711A3/hu
Priority to ES01958325T priority patent/ES2338987T3/es
Priority to CA2416808A priority patent/CA2416808C/en
Priority to EP01958325A priority patent/EP1305322B1/de
Priority to KR1020037001485A priority patent/KR100801207B1/ko
Priority to PCT/IL2001/000713 priority patent/WO2002011666A2/en
Priority to NZ523664A priority patent/NZ523664A/en
Priority to BR0112835-3A priority patent/BR0112835A/pt
Priority to JP2002517004A priority patent/JP2004505898A/ja
Priority to US10/343,105 priority patent/US7186703B2/en
Priority to AU8004301A priority patent/AU8004301A/xx
Priority to CZ2003208A priority patent/CZ2003208A3/cs
Priority to AT01958325T priority patent/ATE455120T1/de
Priority to CNB01816806XA priority patent/CN100467476C/zh
Priority to AU2001280043A priority patent/AU2001280043B2/en
Priority to DE60141074T priority patent/DE60141074D1/de
Publication of IL137672A0 publication Critical patent/IL137672A0/xx
Priority to US11/652,309 priority patent/US7687483B2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/11—Esters of phosphoric acids with hydroxyalkyl compounds without further substituents on alkyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Communicable Diseases (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Fats And Perfumes (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
IL13767200A 2000-08-03 2000-08-03 Derivatives of branched-chain lipophilic molecules and uses thereof IL137672A0 (en)

Priority Applications (19)

Application Number Priority Date Filing Date Title
IL13767200A IL137672A0 (en) 2000-08-03 2000-08-03 Derivatives of branched-chain lipophilic molecules and uses thereof
BR0112835-3A BR0112835A (pt) 2000-08-03 2001-08-01 Derivados de moléculas lipofìlicas de cadeia ramificada e seus usos
JP2002517004A JP2004505898A (ja) 2000-08-03 2001-08-01 分岐鎖状親油性分子の誘導体及びそれらの使用
ES01958325T ES2338987T3 (es) 2000-08-03 2001-08-01 Derivados de moleculas lipofilicas de cadena ramificada y usos de los mismos.
CA2416808A CA2416808C (en) 2000-08-03 2001-08-01 Derivatives of branched-chain lipophilic molecules and uses thereof
EP01958325A EP1305322B1 (de) 2000-08-03 2001-08-01 Derivate von kettenverzweigten lipophilen molekülen und deren verwendung
KR1020037001485A KR100801207B1 (ko) 2000-08-03 2001-08-01 분지-사슬 친지질성 분자의 유도체 및 그것의 사용
PCT/IL2001/000713 WO2002011666A2 (en) 2000-08-03 2001-08-01 Derivatives of branched-chain lipophilic molecules and uses thereof
NZ523664A NZ523664A (en) 2000-08-03 2001-08-01 Derivatives of branched-chain lipophilic molecules and uses thereof
IL15424601A IL154246A0 (en) 2000-08-03 2001-08-01 Derivatives of branched-chain lipophilic molecules and uses thereof
HU0301711A HUP0301711A3 (en) 2000-08-03 2001-08-01 Derivatives of branched-chain lipophilic molecules and uses thereof
US10/343,105 US7186703B2 (en) 2000-08-03 2001-08-01 Derivatives of branched-chain lipophilic molecules and uses thereof
AU8004301A AU8004301A (en) 2000-08-03 2001-08-01 Derivatives of branched-chain lipophilic molecules and uses thereof
CZ2003208A CZ2003208A3 (cs) 2000-08-03 2001-08-01 Deriváty lipofilních molekul s větveným řetězcem a jejich použití
AT01958325T ATE455120T1 (de) 2000-08-03 2001-08-01 Derivate von kettenverzweigten lipophilen molekülen und deren verwendung
CNB01816806XA CN100467476C (zh) 2000-08-03 2001-08-01 支化链亲脂性分子衍生物及其用途
AU2001280043A AU2001280043B2 (en) 2000-08-03 2001-08-01 Derivatives of branched-chain lipophilic molecules and uses thereof
DE60141074T DE60141074D1 (de) 2000-08-03 2001-08-01 Derivate von kettenverzweigten lipophilen molekülen und deren verwendung
US11/652,309 US7687483B2 (en) 2000-08-03 2007-01-11 Derivatives of branch-chain lipophilic molecular and uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL13767200A IL137672A0 (en) 2000-08-03 2000-08-03 Derivatives of branched-chain lipophilic molecules and uses thereof

Publications (1)

Publication Number Publication Date
IL137672A0 true IL137672A0 (en) 2001-10-31

Family

ID=11074480

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13767200A IL137672A0 (en) 2000-08-03 2000-08-03 Derivatives of branched-chain lipophilic molecules and uses thereof

Country Status (16)

Country Link
US (2) US7186703B2 (de)
EP (1) EP1305322B1 (de)
JP (1) JP2004505898A (de)
KR (1) KR100801207B1 (de)
CN (1) CN100467476C (de)
AT (1) ATE455120T1 (de)
AU (2) AU8004301A (de)
BR (1) BR0112835A (de)
CA (1) CA2416808C (de)
CZ (1) CZ2003208A3 (de)
DE (1) DE60141074D1 (de)
ES (1) ES2338987T3 (de)
HU (1) HUP0301711A3 (de)
IL (1) IL137672A0 (de)
NZ (1) NZ523664A (de)
WO (1) WO2002011666A2 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6518311B2 (en) * 1997-07-09 2003-02-11 D-Pharm Ltd. Use of branched-chain fatty acids and derivatives thereof for the treatment of pain
US7582678B2 (en) 1997-07-09 2009-09-01 D-Pharm Limited Use of branched-chain fatty acids and derivatives thereof for the treatment of pain
CA2425215C (en) * 2000-10-10 2009-12-29 University Of North Carolina At Chapel Hill Compositions and methods for enhancing paracellular permeability across epithelial and endothelial barriers
AU2003211052A1 (en) 2002-02-11 2003-09-04 Vertex Pharmaceuticals Incorporated Phospholipids as caspase inhibitor prodrugs
AU2003224087B2 (en) 2002-04-18 2009-03-05 Opko Pharmaceuticals, Llc. Means and methods for the specific inhibition of genes in cells and tissue of the CNS and/or eye
US7148342B2 (en) 2002-07-24 2006-12-12 The Trustees Of The University Of Pennyslvania Compositions and methods for sirna inhibition of angiogenesis
WO2005051298A2 (en) 2003-11-19 2005-06-09 Metabasis Therapeutics, Inc. Novel phosphorus-containing thyromimetics
US8153435B1 (en) 2005-03-30 2012-04-10 Tracer Detection Technology Corp. Methods and articles for identifying objects using encapsulated perfluorocarbon tracers
US20090232879A1 (en) 2005-05-26 2009-09-17 Metabasis Therapeutics, Inc. Thyromimetics for the Treatment of Fatty Liver Diseases
AU2006249347A1 (en) * 2005-05-26 2006-11-30 Metabasis Therapeutics, Inc. Novel phosphorus-containing thyromimetics
US8703179B2 (en) * 2006-05-11 2014-04-22 Kimberly-Clark Worldwide, Inc. Mucosal formulation
EP2180788B1 (de) * 2007-08-10 2016-12-21 Basil Rigas Entzündungshemmende verbindungen und ihre verwendungen
EP2262512A1 (de) * 2008-02-28 2010-12-22 Henry Ford Health System Zusammensetzungen und verfahren zur verwendung von stromazellen zur verstärkung der behandlung von schäden des zentralen nervensystems
WO2010107487A2 (en) * 2009-03-18 2010-09-23 Wu Nian Lipid-drug conjugates for drug delivery
JP5853869B2 (ja) * 2012-06-07 2016-02-09 日油株式会社 ホスホリルコリン基含有化合物及びその製造法
KR20190104524A (ko) 2016-11-21 2019-09-10 바이킹 테라퓨틱스 인코포레이티드 당원축적질환의 치료 방법
EP3634426A4 (de) 2017-06-05 2021-04-07 Viking Therapeutics, Inc. Zusammensetzungen zur behandlung von fibrose
EA202091979A1 (ru) 2018-03-22 2021-06-22 Вайкинг Терапьютикс, Инк. Кристаллические формы и способы получения кристаллических форм соединения
US12102646B2 (en) 2018-12-05 2024-10-01 Viking Therapeutics, Inc. Compositions for the treatment of fibrosis and inflammation

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3006946A (en) 1953-03-04 1961-10-31 Union Carbide Corp Production of heterocyclic phosphoruscontaining compounds and products
US3260688A (en) 1962-08-10 1966-07-12 Toyo Koatsu Ind Inc Resin compositions for producing cellular masses and process for producing a cellular product
US3260668A (en) 1964-11-04 1966-07-12 Dow Chemical Co Alkaline scale control in saline water conversion equipment
DE2038829C3 (de) * 1970-08-05 1975-11-13 Chemische Werke Huels Ag, 4370 Marl Zusatzmittel zu Mörtel oder Beton auf Zementbasis
LU65735A1 (de) * 1972-07-17 1974-01-28
DE2930756A1 (de) * 1979-07-28 1981-02-26 Cassella Ag Klotzhilfsmittel und verfahren zum faerben von cellulosefasern bzw. gemischen von cellulosefasern zusammen mit synthesefasern mit schwefel-, schwefelkuepen-, kuepen- und reaktivfarbstoffen
JPS6038363B2 (ja) * 1979-11-27 1985-08-31 ライオン株式会社 ヘアリンス剤
JPS5716064A (en) * 1980-07-04 1982-01-27 Dai Ichi Kogyo Seiyaku Co Ltd Dye dispersion
JPS57112317A (en) * 1980-12-29 1982-07-13 Lion Corp Hairdressing agent composition
JPS5984824A (ja) * 1982-11-08 1984-05-16 Takeda Chem Ind Ltd 抗腫瘍剤
JPS6072829A (ja) * 1983-09-29 1985-04-24 Kao Corp ベシクル用組成物
JPS60184092A (ja) * 1984-03-01 1985-09-19 Kao Corp リン酸エステルおよびその製法
JPH0832832B2 (ja) 1984-03-09 1996-03-29 花王株式会社 加熱瀝青質用添加剤
US4670575A (en) * 1984-06-05 1987-06-02 Kao Corporation Process for purification of phosphoric mono esters
JPS61129189A (ja) * 1984-11-28 1986-06-17 Kao Corp リン酸エステルまたはその塩の精製方法
US4736051A (en) * 1985-03-20 1988-04-05 Kao Corporation Process for the preparation of an alkali metal salt of a diester phosphoric acid
US4751320A (en) * 1985-11-27 1988-06-14 Kao Corporation Phosphoric ester and process for producing same
CA1338627C (en) 1985-12-04 1996-10-01 Hansjorg Eibl Pharmaceuticals based on phosphoric acid esters for use in tumor therapy, and process for their preparation
US5916884A (en) * 1985-12-04 1999-06-29 Max-Planck-Gesellschaft Zur Foederung Der Wissenschaften Compositions containing a mixture of phosphorus compounds and alkylglycerols
JPS62177008A (ja) * 1986-01-29 1987-08-03 Kao Corp 共重合体の製造法
JPS63122775A (ja) 1986-11-12 1988-05-26 Kao Corp 油ゲル化剤
JPH01290604A (ja) * 1988-05-18 1989-11-22 Dai Ichi Kogyo Seiyaku Co Ltd 水中崩壊性良好な農薬粒剤
WO1989011299A1 (en) 1988-05-18 1989-11-30 State Of Oregon Acting By And Through The State Bo Method for delivery of therapeutic agents to target brain tissue using monoclonal antibody conjugates
US5059415A (en) 1989-02-21 1991-10-22 The State Of Oregon Acting By And Through The Oregon State Board Of Higher Education On Behalf Of Oregon Health Method for diagnostically imaging lesions in the brain inside a blood-brain barrier
FR2677360B1 (fr) * 1991-06-05 1995-04-14 Atta Composes amphiphiles perfluoroalkyles du phosphore, leurs preparations et leurs applications notamment dans le domaine biomedical.
US5846516A (en) * 1992-06-03 1998-12-08 Alliance Pharmaceutial Corp. Perfluoroalkylated amphiphilic phosphorus compounds: preparation and biomedical applications
JP2710900B2 (ja) * 1992-09-02 1998-02-10 株式会社ディ・ディ・エス研究所 酸性官能基を有する脂質誘導体及び同誘導体によって被覆された微粒子キャリヤー
US5491004A (en) * 1994-05-26 1996-02-13 Henkel Corporation Process for applying a low soiling fiber finish
DE69623214T2 (de) * 1995-09-29 2003-04-30 Dainippon Ink And Chemicals, Inc. Verfahren zur Herstellung von Polyestermischungen auf Basis von Polylactiden
JP3747091B2 (ja) * 1996-03-22 2006-02-22 株式会社クラブコスメチックス アポトーシス誘導剤
US6030961A (en) * 1997-03-11 2000-02-29 Bar-Ilan Research & Development Co., Ltd. Oxyalkylene phosphate compounds and uses thereof
ZA984836B (en) * 1997-06-04 1999-06-04 Biocompatibles Ltd Compounds
ZA984837B (en) * 1997-06-04 1999-06-04 Biocompatibles Ltd Phosphate compounds
IL121269A0 (en) 1997-07-09 1998-01-04 Dpharm Ltd Compositions and methods for reversibly increasing permeability of biomembranes
IL121268A0 (en) * 1997-07-09 1998-01-04 Dpharm Ltd Branched chain fatty acids their derivatives and use in the treatment of central nervous system disorders
JP2000053897A (ja) * 1998-08-07 2000-02-22 Kao Corp インクジェット記録用水系インク

Also Published As

Publication number Publication date
CA2416808A1 (en) 2002-02-14
CA2416808C (en) 2011-11-22
CN1633440A (zh) 2005-06-29
KR100801207B1 (ko) 2008-02-05
CN100467476C (zh) 2009-03-11
BR0112835A (pt) 2003-10-21
HUP0301711A2 (hu) 2003-09-29
HUP0301711A3 (en) 2007-05-29
US20070135381A1 (en) 2007-06-14
KR20030024823A (ko) 2003-03-26
DE60141074D1 (de) 2010-03-04
CZ2003208A3 (cs) 2003-10-15
EP1305322B1 (de) 2010-01-13
AU2001280043B2 (en) 2007-05-24
EP1305322A4 (de) 2005-04-13
JP2004505898A (ja) 2004-02-26
US7186703B2 (en) 2007-03-06
EP1305322A2 (de) 2003-05-02
US7687483B2 (en) 2010-03-30
AU2001280043B8 (en) 2002-02-18
ES2338987T3 (es) 2010-05-14
WO2002011666A2 (en) 2002-02-14
ATE455120T1 (de) 2010-01-15
AU8004301A (en) 2002-02-18
WO2002011666A3 (en) 2002-07-11
US20030186897A1 (en) 2003-10-02
NZ523664A (en) 2004-07-30

Similar Documents

Publication Publication Date Title
IL137672A0 (en) Derivatives of branched-chain lipophilic molecules and uses thereof
ATE316083T1 (de) Adamantanderivate
MXPA02003596A (es) Composiciones farmaceuticas novedosas de farmacos anti tubercular y procedimiento para su preparacion.
IS6520A (is) Ný efnasambönd
AU2002324914A1 (en) Pharmaceutical compositions of drug-oligomer conjugates and methods of treating diseases therewith
PL366198A1 (en) Novel compounds
PL367682A1 (en) Dolastatin 10 derivatives
NO20012774D0 (no) Preparat og metode hvor det gjöres bruk av eteriske planteoljer
HUP0301269A3 (en) Phthalazinone derivatives and pharmaceutical compositions containing them
BR0208338A (pt) Derivados de piridina
BR9912327A (pt) Inibidores da uroquinase
EA200100154A1 (ru) Бензоциклогептены, способ их получения, содержащие их фармацевтические препараты и их применение для получения лекарственных средств
PL1654253T3 (pl) Podstawione pochodne 3-pirolidynoindolu
IL153680A0 (en) Aplidine derivatives and methods for the preparation thereof
EP1461313A4 (de) Inhibitoren von humanem adam-10
BG106155A (en) Novel derivatives and analogues of galanthamin
PL342614A1 (en) Anticarcinogenic drugs
BR0112807A (pt) Derivados de indol e sua aplicação como medicamento
SE0003476D0 (sv) Compounds
HUP0300402A3 (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain and pharmaceutical compositions containing them
ATE280588T1 (de) Dextran-leptin konjugate, pharmazeutische zusammentsetzungen und verbundene verfahren
TR200402230T4 (tr) O-ikameli 6-metil-tramadol-türevleri
DE69917005D1 (de) Substituierte pyrrolobenzimidazolderivate zur entzündungshemmung
ATE299025T1 (de) Pharmazeutische zubereitung enthaltend zytostatika und elektronenakzeptoren zur behandlung von krebs
MXPA04001655A (es) Derivados de acido ascorbico, metodos de sintesis y uso farmaceutico de los mismos.